Two of Washington’s most powerful lawmakers told CNBC they believe Congress will strike a coronaviurs relief package, although the timing is still unknown. Congress and the Trump administration have struggled to strike an aid agreement for several days, even as key relief benefits expired. While negotiations continue, markets got a fresh look at employment, with new data… Read More »
As Biogen preps for its closely watched aducanumab FDA filing in Alzheimer’s disease, a patent threat for the company’s top-selling medicine is causing concern for one team of analysts. In a note to clients Tuesday, Bernstein analyst Ronny Gal and his team downgraded Biogen’s stock—from outperform to market-perform—based on the belief that Mylan will win… Read More »
Vanderbilt University Medical Center researchers are developing a clinical decision support tool to help avoid over- and under-prescribing of opioids for women undergoing cesarean section. Nearly a third of U.S. women will have a cesarean section during childbirth. However, opioid prescriptions for these new mothers often are either insufficient to meet their pain needs or… Read More »